<DOC>
	<DOCNO>NCT01956487</DOCNO>
	<brief_summary>Bioequivalence propafenone hydrochloride capsule manufacture two different site</brief_summary>
	<brief_title>Bioequivalence RYTHMOL SR® Manufactured Two Different Sites</brief_title>
	<detailed_description>This Phase 1 , randomize , open-label , single-dose , three-period , crossover study assess bioequivalence propafenone hydrochloride manufacture two different site healthy adult volunteer . Approximately 36 subject receive 3 single dos propafenone hydrochloride 425mg , administer separately , fast state 7 day washout period dos . Propafenone hydrochloride antiarrhythmic indicate prolong time recurrence symptomatic atrial fibrillation patient episodic ( likely paroxysmal persistent ) atrial fibrillation structural heart disease . A follow-up visit occur 7-10 day final dose study drug .</detailed_description>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Propafenone</mesh_term>
	<criteria>Male female 18 55 year age inclusive , time signing informed consent . Body weight great equal 50kg BMI within range 18.5 31.0kg/m2 ( inclusive ) . Healthy determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . AST , ALT , alkaline phosphatase bilirubin less equal 1.5xULN ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) . A female subject eligible participate postmenopausal stable regimine approve contracetive Capable give write informed consent , A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen . Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy drug/alcohol screen . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine . A positive test HIV antibody . History regular alcohol consumption within 6 month study define : average weekly intake &gt; 14 drink male &gt; 7 drink female . One drink equivalent 12g alcohol : 12 ounce ( 360ml ) beer , 5 ounce ( 150ml ) wine 1.5 ounce ( 45ml ) 80 proof distil spirit . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : either 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . The subject donate blood blood product excess 500mL within 56 day period . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . Pregnant female determine positive serum urine hCG test screen prior dosing . Lactating female . Unwillingness inability follow procedure outline protocol . Subject mentally legally incapacitate . History sensitivity heparin heparininduced thrombocytopenia . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . Consumption red wine , seville orange , grapefruit grapefruit juice 7 day prior first dose study medication . Unwilling abstain alcohol 48 hour prior screen 48 hour prior start dose collection final pharmacokinetic sample treatment period . Subjects preexist condition interfere normal gastrointestinal anatomy motility , hepatic and/or renal function , could interfere absorption , metabolism , and/or excretion study drug . Subjects history cholecystectomy , peptic ulceration , inflammatory bowel disease pancreatitis exclude . The subject 's systolic blood pressure outside range 90140 mmHg , diastolic blood pressure outside range 4590mmHg heart rate outside range 55100bpm female subject 50100bpm male subject . Screening ECG within normal limts age gender Evidence previous myocardial infarction . Any conduction abnormality ( include specific leave right complete bundle branch block , AV block [ 2nd degree high ] , Wolf Parkinson White [ WPW ] syndrome , nonsustained sustain ventricular tachycardia ( 3 consecutive ventricular ectopic beat ) , sinus pause &gt; 3 second , significant arrhythmia , opinion principal investigator GSK medical monitor , interfere</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>RYTHMOL SR®</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Propafenone</keyword>
	<keyword>Pharmavokinetics</keyword>
</DOC>